Reporting to shareholders
- GSK reports formally to shareholders twice a year, when our half-year and full-year results are announced. The CEO and CFO give presentations on the half-year and full-year results in face-to-face meetings with institutional investors, analysts and the media, which are also accessible via web-cast and teleconference. You can view these presentations on GSK.com.
- To ensure that the Non-Executive Directors are aware of and understand the views of major shareholders, our Board has in place a briefing process, which is managed by the Chair. It focuses on sector-specific issues as well as general shareholder preferences. Each year the Non-Executive Directors also receive an external review of shareholder opinion.
- Our Investor Relations department, with offices in London and Philadelphia, acts as a focal point for contacts with investors throughout the world. The CEO, CFO and Chair maintain a dialogue with institutional shareholders on performance, plans and objectives through a programme of regular meetings. They also speak regularly at external conferences and presentations.
- The Company Secretary acts as a focal point for communications on corporate governance matters. We also have a small central Corporate Responsibility (CR) team which co-ordinates strategy, policy development and reporting specifically with respect to CR and communicates with socially responsible investors and other stakeholders.
- The Chair, Committee Chairs, and the Company Secretary hold annual meetings with major shareholders to discuss governance matters.
- The Remuneration Committee Chair, the Chair, the Head of Human Resources and the Company Secretary hold annual meetings with major shareholders to discuss executive remuneration and governance matters.
- Our Annual General Meeting (AGM) takes place in London, and notification is sent to shareholders at least one month in advance. At the Meeting a business presentation is made to shareholders and all directors able to attend are available, formally during the Meeting, and informally afterwards, for questions. Committee Chairs ordinarily attend the AGM to respond to shareholders’ questions.
- The results of any voting at the meeting are released to the London Stock Exchange and published on this website.
You might also like
Sarbanes-Oxley Act 2002
The Sarbanes-Oxley Act of 2002 established new standards for corporate accountability in the USA
Find out about our various board committees
Find out about GSK compliance
At GSK we are committed to operating at the highest standards of corporate governance
Board of directors and leadership team
Our board of directors and global leadership team
GSK at a glance
Key achievements in pursuing our purpose to get ahead of disease